GlassScriptPhysician profile
Edward Carey Spoon
NPI 1528060183
$2,009.64
in general payments reported to CMS, 2019-2025
28 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $341 · 2021: $299 · 2022: $406 · 2023: $281 · 2024: $127 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $736.23 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Mayne Pharma Commercial LLC | $197.48 | 2022-2025 | Annovera, Nextstellis |
| Hologic Sales and Service, LLC | $121.43 | 2021-2023 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $113.23 | 2019-2022 | |
| Therapeuticsmd, INC. | $96.55 | 2020-2022 | |
| Avion Pharmaceuticals | $74.78 | 2019-2023 | Balcoltra |
| Sumitomo Pharma America, INC. | $68.06 | 2024-2025 | Myfembree |
| Sage Therapeutics, LLC | $60.31 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $47.36 | 2020 | |
| Momentis Surgical INC. | $45.00 | 2022 | |
| Radius Health, INC. | $41.29 | 2021-2022 | |
| Astellas Pharma US INC | $37.65 | 2024-2025 | Veozah |
| Exact Sciences Corporation | $36.44 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Becton, Dickinson and Company | $34.78 | 2023-2024 | Bd Onclarity |
| Allergan, INC. | $34.66 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $29.35 | 2019-2024 | Injectafer |
| Dexcom, INC. | $28.43 | 2025 | Dexcom G6 Transmitter |
| Myovant Sciences INC. | $25.92 | 2021-2022 | |
| Forte Bio-Pharma LLC | $23.99 | 2019 | |
| Lupin INC. | $23.42 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.38 | 2022 | |
| Organon LLC | $18.78 | 2023 | Nexplanon |
| Agile Therapeutics, INC. | $17.54 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.99 | 2020 | |
| Amag Pharmaceuticals, INC. | $16.14 | 2020 | |
| Minerva Surgical, INC | $15.44 | 2025 | |
| Merck Sharp & Dohme LLC | $14.57 | 2022 | |
| Evofem Biosciences, INC. | $14.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Spoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.